LiveRamp Holdings earnings release, May 18, 2026
Exhibit
99.1
LIVERAMP
ANNOUNCES FOURTH QUARTER AND FISCAL YEAR 2026 RESULTS
Q4
Revenue up 9% year-over-year
Q4
Annual Recurring Revenue up 8% year-over-year
Q4
Subscription Net Retention improved to 107%
FY26 record annual Operating Cash Flow of $168 million and Share Repurchases of $194 million
LiveRamp
Enters into Definitive Agreement to be Acquired by Publicis Groupe in All-Cash Transaction with an Equity Value of $2.5 billion
SAN
FRANCISCO, Calif., May 17, 2026 —LiveRamp®
(NYSE: RAMP), a leading data collaboration platform, today announced its financial results for the quarter and fiscal year ended
March 31, 2026.
Q4
Financial Highlights
Unless otherwise indicated, all comparisons are to the prior year period.
Fiscal
Year 2026 Financial Highlights
Unless otherwise indicated, all comparisons are to the prior year period.
P¹
A reconciliation between GAAP and non-GAAP results is provided in the schedules in this press release.
Commenting on the results,
CEO Scott Howe said:
"We finished FY26 on a strong note, with Q4 revenue and operating income ahead of consensus and ARR growth accelerating sequentially. We also achieved record operating cash flow in FY26, and returned over 100% to shareholders through buybacks. We continue to leverage AI to make our platform faster, more effective and easier to use, including the recent introduction of AI agent accessibility, enabling specialized AI agents to autonomously collaborate with any partner."
Howe continued:
“In addition, we announced an agreement to be acquired by Publicis Groupe, delivering significant and certain value to LiveRamp shareholders. This transaction reflects the strength of our business, the value of our platform and the strategic role
LiveRamp plays in an AI-driven market. Together, we believe we can accelerate data collaboration and the delivery of AI capabilities that help customers and partners advance agentic transformation and derive more value, faster.”
P²
GAAP and
Non-GAAP Results
The following table summarizes the Company’s financial results for the fourth quarter and fiscal year ended March 31, 2026 ($ in millions, except per share amounts):
Totals and year-over-year changes may not reconcile due to rounding.
A detailed discussion of our non-GAAP financial measures and a reconciliation between GAAP and non-GAAP results is provided in the schedules to this press release.
P³
Additional
Business Highlights & Metrics
P⁴
Transaction with Publicis Groupe
In a separate press release issued today, LiveRamp announced that it has entered into a definitive agreement to be acquired by Publicis
Groupe. Under the terms of the agreement, Publicis Groupe will acquire all of the outstanding shares of LiveRamp for $38.50 per share in an all-cash transaction for an equity value of $2.5 billion. This represents a premium of 30% to LiveRamp’s closing stock price on May 15, 2026, the last full trading day prior to the transaction announcement. The transaction is expected to close by the end of calendar 2026, subject to customary closing conditions, including approval by LiveRamp shareholders. The transaction press release is available on the LiveRamp investor relations website.
Given the announced transaction, LiveRamp will not host its previously scheduled earnings conference call or provide financial guidance in conjunction with this earnings release.
About
LiveRamp
LiveRamp is a leading data collaboration technology company, empowering marketers and media owners to deliver and measure marketing performance everywhere it matters. LiveRamp’s data collaboration network seamlessly unites data across advertisers, ad tech platforms, publishers, data providers, and commerce media networks—unlocking insights that deliver transformational consumer experiences, and drive measurable business outcomes. As consumers embrace AI-powered experiences, the LiveRamp data collaboration network expands the breadth and accuracy of the data on which marketing AI capabilities operate. Our platform is engineered for AI agent accessibility, facilitating autonomous data collaboration between the specialized AI agents utilized by our customers and partners. Built on a foundation of strict neutrality, interoperability, and global scale, LiveRamp enables organizations to maximize the value of their data while accelerating business growth.
LiveRamp is headquartered in San Francisco, California, with offices worldwide. Learn more at LiveRamp.com.
P⁵
Forward-Looking
Statements
Financial statements
Income Statement ($ in millions, except per share amounts)
| GAAP – Q4 FY26 | GAAP – FY26 | Non-GAAP – Q4 FY26 | Non-GAAP – FY26 | |
|---|---|---|---|---|
| Subscription revenue | 158 | 614 | -- | -- |
| YoY change % | 9 | 8 | -- | -- |
| Marketplace & Other revenue | 49 | 199 | -- | -- |
| YoY change % | 11 | 12 | -- | -- |
| Total revenue | 206 | 813 | -- | -- |
| YoY change % | 9 | 9 | -- | -- |
| Gross profit | 146 | 575 | 149 | 591 |
| % Gross margin | 71 | 71 | 72 | 73 |
| YoY change, pts | 1 | 0 | 1 | -1 |
| Operating income | 15 | 83 | 40 | 182 |
| % Operating margin | 7 | 10 | 20 | 22 |
| YoY change, pts | 14 | 10 | 7 | 4 |
| Net earnings | 71 | 146 | 33 | 148 |
| Diluted earnings per share | 1.12 | 2.24 | 0.52 | 2.27 |
| Shares to calculate diluted EPS | 63.4 | 65 | 63.4 | 65 |
| YoY change % | -4 | -2 | -6 | -4 |
| Operating cash flow | 59 | 168 | ||
| Free cash flow | 59 | 166 |
Income Statement
For the three months ended March 31, — (Dollars in thousands, except per share amounts)
| For the three months ended March 31, – 2026 | For the three months ended March 31, – 2025 | For the three months ended March 31, – $ – Variance | For the three months ended March 31, – % – Variance | ||
|---|---|---|---|---|---|
| Revenues | 206,092 | 188,724 | 17,368 | 9.2% | |
| Cost of revenue | 60,548 | 57,929 | 2,619 | 4.5% | |
| Gross profit | 145,544 | 130,795 | 14,749 | 11.3% | |
| % Gross margin | 70.6% | 69.3% | |||
| Operating expenses | Research and development | 37,756 | 45,926 | -8,170 | -17.8% |
| Operating expenses | Sales and marketing | 56,192 | 56,961 | -769 | -1.4% |
| Operating expenses | General and administrative | 32,988 | 32,175 | 813 | 2.5% |
| Operating expenses | Gains, losses and other items, net | 3,315 | 7,241 | -3,926 | -54.2% |
| Operating expenses | Total operating expenses | 130,251 | 142,303 | -12,052 | -8.5% |
| Operating expenses | Income (loss) from operations | 15,293 | -11,508 | 26,801 | N/A |
| Operating expenses | % Margin | 7.4% | -6.1% | ||
| Operating expenses | Total other income, net | 3,967 | 4,762 | -795 | -16.7% |
| Operating expenses | Income (loss) from continuing operations before income taxes | 19,260 | -6,746 | 26,006 | N/A |
| Operating expenses | Income tax benefit | -50,476 | -479 | -49,997 | -10437.8% |
| Operating expenses | Net earnings (loss) from continuing operations | 69,736 | -6,267 | 76,003 | N/A |
| Operating expenses | Earnings from discontinued operations, net of tax | 1,176 | 1,176 | N/A | |
| Operating expenses | Net earnings (loss) | 70,912 | -6,267 | 77,179 | 1231.5% |
| Basic earnings (loss) per share: | Continuing operations | 1.12 | -0.1 | 1.21 | N/A |
| Basic earnings (loss) per share: | Discontinued operations | 0.02 | 0.02 | N/A | |
| Basic earnings (loss) per share: | Basic earnings (loss) per share | 1.14 | -0.1 | 1.23 | N/A |
| Diluted earnings (loss) per share: | Continuing operations | 1.1 | -0.1 | 1.2 | N/A |
| Diluted earnings (loss) per share: | Discontinued operations | 0.02 | 0.02 | N/A | |
| Diluted earnings (loss) per share: | Diluted earnings (loss) per share | 1.12 | -0.1 | 1.21 | N/A |
| Diluted earnings (loss) per share: | Basic weighted average shares | 62,382 | 65,957 | ||
| Diluted earnings (loss) per share: | Diluted weighted average shares | 63,382 | 65,957 |
Income Statement
For the twelve months ended March 31, — (Dollars in thousands, except per share amounts)
| For the twelve months ended March 31, – 2026 | For the twelve months ended March 31, – 2025 | For the twelve months ended March 31, – $ – Variance | For the twelve months ended March 31, – % – Variance | ||
|---|---|---|---|---|---|
| Revenues | 812,940 | 745,580 | 67,360 | 9.0% | |
| Cost of revenue | 238,117 | 215,910 | 22,207 | 10.3% | |
| Gross profit | 574,823 | 529,670 | 45,153 | 8.5% | |
| % Gross margin | 70.7% | 71.0% | |||
| Operating expenses | Research and development | 148,139 | 176,668 | -28,529 | -16.1% |
| Operating expenses | Sales and marketing | 205,647 | 213,106 | -7,459 | -3.5% |
| Operating expenses | General and administrative | 132,581 | 126,499 | 6,082 | 4.8% |
| Operating expenses | Gains, losses and other items, net | 4,990 | 7,993 | -3,003 | -37.6% |
| Operating expenses | Total operating expenses | 491,357 | 524,266 | -32,909 | -6.3% |
| Operating expenses | Income from operations | 83,466 | 5,404 | 78,062 | 1444.5% |
| Operating expenses | % Margin | 10.3% | 0.7% | ||
| Operating expenses | Total other income, net | 14,598 | 17,436 | -2,838 | -16.3% |
| Operating expenses | Income from continuing operations before income taxes | 98,064 | 22,840 | 75,224 | 329.4% |
| Operating expenses | Income tax expense (benefit) | -46,712 | 25,342 | -72,054 | N/A |
| Operating expenses | Net earnings (loss) from continuing operations | 144,776 | -2,502 | 147,278 | N/A |
| Operating expenses | Earnings from discontinued operations, net of tax | 1,176 | 1,688 | -512 | -30.3% |
| Operating expenses | Net earnings (loss) | 145,952 | -814 | 146,766 | 18030.2% |
| Basic earnings (loss) per share: | Continuing operations | 2.26 | -0.04 | 2.3 | N/A |
| Basic earnings (loss) per share: | Discontinued operations | 0.02 | 0.03 | -0.01 | -28.1% |
| Basic earnings (loss) per share: | Basic earnings (loss) per share | 2.28 | -0.01 | 2.29 | N/A |
| Diluted earnings (loss) per share: | Continuing operations | 2.23 | -0.04 | 2.26 | N/A |
| Diluted earnings (loss) per share: | Discontinued operations | 0.02 | 0.03 | -0.01 | -29.2% |
| Diluted earnings (loss) per share: | Diluted earnings (loss) per share | 2.24 | -0.01 | 2.26 | N/A |
| Diluted earnings (loss) per share: | Basic weighted average shares | 64,105 | 66,126 | ||
| Diluted earnings (loss) per share: | Diluted weighted average shares | 65,045 | 66,126 |
Income Statement
For the three months ended March 31, — (Dollars in thousands, except per share amounts)
| For the three months ended March 31, – 2026 | For the three months ended March 31, – 2025 | For the twelve months ended March 31, – 2026 | For the twelve months ended March 31, – 2025 | |
|---|---|---|---|---|
| Income (loss) from continuing operations before income taxes | 19,260 | -6,746 | 98,064 | 22,840 |
| Income tax expense (benefit) | -50,476 | -479 | -46,712 | 25,342 |
Income Statement
For the three months ended March 31, — (Dollars in thousands)
| For the three months ended March 31, – 2026 | For the three months ended March 31, – 2025 | For the twelve months ended March 31, – 2026 | For the twelve months ended March 31, – 2025 | ||
|---|---|---|---|---|---|
| Income (loss) from operations | 15,293 | -11,508 | 83,466 | 5,404 | |
| Operating income (loss) margin | 7.4% | -6.1% | 10.3% | 0.7% | |
| Excluded items: | Purchased intangible asset amortization (cost of revenue) | 2,750 | 3,135 | 11,000 | 14,415 |
| Excluded items: | Non-cash stock compensation (cost of revenue and operating expenses) | 18,930 | 24,166 | 82,988 | 107,979 |
| Excluded items: | Restructuring and merger charges (gains, losses, and other) | 3,315 | 7,241 | 4,990 | 7,993 |
| Excluded items: | Total excluded items | 24,995 | 34,542 | 98,978 | 130,387 |
| Excluded items: | Income from operations before excluded items | 40,288 | 23,034 | 182,444 | 135,791 |
| Excluded items: | Non-GAAP operating income margin | 19.5% | 12.2% | 22.4% | 18.2% |
Income Statement
For the three months ended March 31, — (Dollars in thousands)
| For the three months ended March 31, – 2026 | For the three months ended March 31, – 2025 | For the twelve months ended March 31, – 2026 | For the twelve months ended March 31, – 2025 | ||
|---|---|---|---|---|---|
| Net earnings (loss) from continuing operations | 69,736 | -6,267 | 144,776 | -2,502 | |
| Income tax expense (benefit) | -50,476 | -479 | -46,712 | 25,342 | |
| Total other income, net | -3,967 | -4,762 | -14,598 | -17,436 | |
| Income (loss) from operations | 15,293 | -11,508 | 83,466 | 5,404 | |
| Depreciation and amortization | 3,320 | 3,803 | 13,399 | 17,207 | |
| EBITDA | 18,613 | -7,705 | 96,865 | 22,611 | |
| Other adjustments: | Non-cash stock compensation (cost of revenue and operating expenses) | 18,930 | 24,166 | 82,988 | 107,979 |
| Other adjustments: | Restructuring and merger charges (gains, losses, and other) | 3,315 | 7,241 | 4,990 | 7,993 |
| Other adjustments: | Other adjustments | 22,245 | 31,407 | 87,978 | 115,972 |
| Other adjustments: | Adjusted EBITDA | 40,858 | 23,702 | 184,843 | 138,583 |
Income Statement
(Dollars in thousands, except per share amounts)
| FY2025 – 6/30/2024 | FY2025 – 9/30/2024 | FY2025 – 12/31/2024 | FY2025 – 3/31/2025 | FY2025 | FY2026 – 6/30/2025 | FY2026 – 9/30/2025 | FY2026 – 12/31/2025 | FY2026 – 3/31/2026 | FY2026 | Yr-to-Yr – FY2026 to FY2025 – % | Yr-to-Yr – FY2026 to FY2025 – $ | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 175,961 | 185,483 | 195,412 | 188,724 | 745,580 | 194,822 | 199,829 | 212,197 | 206,092 | 812,940 | 9.0% | 67,360 | |
| Cost of revenue | 51,749 | 51,234 | 54,998 | 57,929 | 215,910 | 58,319 | 59,594 | 59,656 | 60,548 | 238,117 | 10.3% | 22,207 | |
| Gross profit | 124,212 | 134,249 | 140,414 | 130,795 | 529,670 | 136,503 | 140,235 | 152,541 | 145,544 | 574,823 | 8.5% | 45,153 | |
| % Gross margin | 70.6% | 72.4% | 71.9% | 69.3% | 71.0% | 70.1% | 70.2% | 71.9% | 70.6% | 70.7% | |||
| Operating expenses | Research and development | 44,118 | 43,889 | 42,735 | 45,926 | 176,668 | 39,608 | 36,952 | 33,823 | 37,756 | 148,139 | )% | -28,529 |
| Operating expenses | Sales and marketing | 54,175 | 51,107 | 50,863 | 56,961 | 213,106 | 51,906 | 48,685 | 48,864 | 56,192 | 205,647 | )% | -7,459 |
| Operating expenses | General and administrative | 30,961 | 31,369 | 31,994 | 32,175 | 126,499 | 37,345 | 33,170 | 29,078 | 32,988 | 132,581 | 4.8% | 6,082 |
| Operating expenses | Gains, losses and other items, net | 206 | 397 | 149 | 7,241 | 7,993 | 423 | 1,252 | 3,315 | 4,990 | )% | -3,003 | |
| Operating expenses | Total operating expenses | 129,460 | 126,762 | 125,741 | 142,303 | 524,266 | 129,282 | 118,807 | 113,017 | 130,251 | 491,357 | )% | -32,909 |
| Operating expenses | Income (loss) from operations | -5,248 | 7,487 | 14,673 | -11,508 | 5,404 | 7,221 | 21,428 | 39,524 | 15,293 | 83,466 | 1444.5% | 78,062 |
| Operating expenses | % Margin | )% | 4.0% | 7.5% | )% | 0.7% | 3.7% | 10.7% | 18.6% | 7.4% | 10.3% | ||
| Operating expenses | Total other income, net | 4,444 | 4,197 | 4,033 | 4,762 | 17,436 | 3,709 | 3,544 | 3,378 | 3,967 | 14,598 | )% | -2,838 |
| Operating expenses | Income (loss) from continuing operations before income taxes | -804 | 11,684 | 18,706 | -6,746 | 22,840 | 10,930 | 24,972 | 42,902 | 19,260 | 98,064 | 329.4% | 75,224 |
| Operating expenses | Income tax expense (benefit) | 6,685 | 9,952 | 9,184 | -479 | 25,342 | 3,183 | -2,448 | 3,029 | -50,476 | -46,712 | N/A | -72,054 |
Income Statement
(Dollars in thousands, except per share amounts)
| FY2025 – 6/30/2024 | FY2025 – 9/30/2024 | FY2025 – 12/31/2024 | FY2025 – 3/31/2025 | FY2025 | FY2026 – 6/30/2025 | FY2026 – 9/30/2025 | FY2026 – 12/31/2025 | FY2026 – 3/31/2026 | FY2026 | Yr-to-Yr – FY2026 to FY2025 – % | Yr-to-Yr – FY2026 to FY2025 – $ | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings from discontinued operations, net of tax | 1,688 | 1,688 | 1,176 | 1,176 | -30.3% | -512 | |||||||
| Net earnings (loss) | -7,489 | 1,732 | 11,210 | -6,267 | -814 | 7,747 | 27,420 | 39,873 | 70,912 | 145,952 | N/A | 146,766 | |
| Basic earnings (loss) per share: | Continuing Operations | -0.11 | 0.03 | 0.15 | -0.1 | -0.04 | 0.12 | 0.42 | 0.63 | 1.12 | 2.26 | N/A | 2.3 |
| Basic earnings (loss) per share: | Discontinued Operations | 0 | 0 | 0.03 | 0 | 0.03 | 0 | 0 | 0 | 0.02 | 0.02 | -28.1% | -0.01 |
| Basic earnings (loss) per share: | Basic earnings (loss) per share | -0.11 | 0.03 | 0.17 | -0.1 | -0.01 | 0.12 | 0.42 | 0.63 | 1.14 | 2.28 | N/A | 2.29 |
| Diluted earnings (loss) per share: | Continuing Operations | -0.11 | 0.03 | 0.14 | -0.1 | -0.04 | 0.12 | 0.42 | 0.62 | 1.1 | 2.23 | N/A | 2.26 |
| Diluted earnings (loss) per share: | Discontinued Operations | 0 | 0 | 0.03 | 0 | 0.03 | 0 | 0 | 0 | 0.02 | 0.02 | -29.2% | -0.01 |
| Diluted earnings (loss) per share: | Diluted earnings (loss) per share | -0.11 | 0.03 | 0.17 | -0.1 | -0.01 | 0.12 | 0.42 | 0.62 | 1.12 | 2.24 | N/A | 2.26 |
| Diluted earnings (loss) per share: | Basic weighted average shares | 66,621 | 66,294 | 65,631 | 65,957 | 66,126 | 65,448 | 65,074 | 63,517 | 62,382 | 64,105 | ||
| Diluted earnings (loss) per share: | Diluted weighted average shares | 66,621 | 67,309 | 66,743 | 65,957 | 66,126 | 66,731 | 65,781 | 64,285 | 63,382 | 65,045 |
Income Statement
(Dollars in thousands)
| FY2025 – 6/30/2024 | FY2025 – 9/30/2024 | FY2025 – 12/31/2024 | FY2025 – 3/31/2025 | FY2025 | FY2026 – 6/30/2025 | FY2026 – 9/30/2025 | FY2026 – 12/31/2025 | FY2026 – 3/31/2026 | FY2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Expenses: | Cost of revenue | 51,749 | 51,234 | 54,998 | 57,929 | 215,910 | 58,319 | 59,594 | 59,656 | 60,548 | 238,117 |
| Expenses: | Research and development | 44,118 | 43,889 | 42,735 | 45,926 | 176,668 | 39,608 | 36,952 | 33,823 | 37,756 | 148,139 |
| Expenses: | Sales and marketing | 54,175 | 51,107 | 50,863 | 56,961 | 213,106 | 51,906 | 48,685 | 48,864 | 56,192 | 205,647 |
| Expenses: | General and administrative | 30,961 | 31,369 | 31,994 | 32,175 | 126,499 | 37,345 | 33,170 | 29,078 | 32,988 | 132,581 |
| Expenses: | Gains, losses and other items, net | 206 | 397 | 149 | 7,241 | 7,993 | 423 | 1,252 | 3,315 | 4,990 | |
| Expenses: | Gross profit, continuing operations: | 124,212 | 134,249 | 140,414 | 130,795 | 529,670 | 136,503 | 140,235 | 152,541 | 145,544 | 574,823 |
| Expenses: | % Gross margin | 70.6 | 72.4 | 71.9 | 69.3 | 71 | 70.1% | 70.2% | 71.9% | 70.6% | 70.7% |
| Excluded items: | Purchased intangible asset amortization (cost of revenue) | 3,846 | 3,748 | 3,686 | 3,135 | 14,415 | 2,750 | 2,750 | 2,750 | 2,750 | 11,000 |
| Excluded items: | Non-cash stock compensation (cost of revenue) | 1,596 | 1,499 | 1,455 | 1,615 | 6,165 | 1,541 | 1,452 | 1,033 | 891 | 4,917 |
| Excluded items: | Non-cash stock compensation (research and development) | 10,205 | 10,920 | 10,085 | 10,494 | 41,704 | 8,332 | 6,503 | 5,634 | 5,093 | 25,562 |
| Excluded items: | Non-cash stock compensation (sales and marketing) | 7,093 | 7,383 | 7,278 | 5,716 | 27,470 | 6,014 | 5,469 | 5,018 | 6,419 | 22,920 |
| Excluded items: | Non-cash stock compensation (general and administrative) | 9,091 | 9,266 | 7,942 | 6,341 | 32,640 | 9,523 | 7,093 | 6,446 | 6,527 | 29,589 |
| Excluded items: | Restructuring charges (gains, losses, and other) | 206 | 397 | 149 | 7,241 | 7,993 | 423 | 1,252 | 3,315 | 4,990 | |
| Excluded items: | Total excluded items | 32,037 | 33,213 | 30,595 | 34,542 | 130,387 | 28,583 | 23,267 | 22,133 | 24,995 | 98,978 |
Income Statement
(Dollars in thousands, except per share amounts)
| FY2025 – 6/30/2024 | FY2025 – 9/30/2024 | FY2025 – 12/31/2024 | FY2025 – 3/31/2025 | FY2025 | FY2026 – 6/30/2025 | FY2026 – 9/30/2025 | FY2026 – 12/31/2025 | FY2026 – 3/31/2026 | FY2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income (loss) from continuing operations before income taxes | -804 | 11,684 | 18,706 | -6,746 | 22,840 | 10,930 | 24,972 | 42,902 | 19,260 | 98,064 | |
| Income tax expense (benefit) | 6,685 | 9,952 | 9,184 | -479 | 25,342 | 3,183 | -2,448 | 3,029 | -50,476 | -46,712 | |
| Net earnings (loss) from continuing operations | -7,489 | 1,732 | 9,522 | -6,267 | -2,502 | 7,747 | 27,420 | 39,873 | 69,736 | 144,776 | |
| Earnings from discontinued operations, net of tax | 1,688 | 1,688 | 1,176 | 1,176 | |||||||
| Net earnings (loss) | -7,489 | 1,732 | 11,210 | -6,267 | -814 | 7,747 | 27,420 | 39,873 | 70,912 | 145,952 | |
| Earnings (loss) per share: | Basic | -0.11 | 0.03 | 0.17 | -0.1 | -0.01 | 0.12 | 0.42 | 0.63 | 1.14 | 2.28 |
| Earnings (loss) per share: | Diluted | -0.11 | 0.03 | 0.17 | -0.1 | -0.01 | 0.12 | 0.42 | 0.62 | 1.12 | 2.24 |
| Excluded items: | Purchased intangible asset amortization (cost of revenue) | 3,846 | 3,748 | 3,686 | 3,135 | 14,415 | 2,750 | 2,750 | 2,750 | 2,750 | 11,000 |
| Excluded items: | Non-cash stock compensation (cost of revenue and operating expenses) | 27,985 | 29,068 | 26,760 | 24,166 | 107,979 | 25,410 | 20,517 | 18,131 | 18,930 | 82,988 |
| Excluded items: | Restructuring and merger charges (gains, losses, and other) | 206 | 397 | 149 | 7,241 | 7,993 | 423 | 1,252 | 3,315 | 4,990 | |
| Excluded items: | Total excluded items from continuing operations | 32,037 | 33,213 | 30,595 | 34,542 | 130,387 | 28,583 | 23,267 | 22,133 | 24,995 | 98,978 |
| Excluded items: | Income from continuing operations before income taxes and excluding items | 31,233 | 44,897 | 49,301 | 27,796 | 153,227 | 39,513 | 48,239 | 65,035 | 44,255 | 197,042 |
| Excluded items: | Income tax expense | 7,371 | 10,745 | 12,421 | 7,759 | 38,296 | 9,878 | 12,060 | 16,259 | 11,064 | 49,261 |
Balance Sheet
(Dollars in thousands)
| March 31, – 2026 | March 31, – 2025 | $$ – Variance | % – Variance | ||
|---|---|---|---|---|---|
| Current assets: | Cash and cash equivalents | 379,547 | 413,331 | -33,784 | -8.2% |
| Current assets: | Restricted cash | 595 | -595 | -100.0% | |
| Current assets: | Short-term investments | 7,500 | 7,500 | ||
| Current assets: | Trade accounts receivable, net | 212,977 | 186,169 | 26,808 | 14.4% |
| Current assets: | Refundable income taxes, net | 10,243 | 9,708 | 535 | 5.5% |
| Current assets: | Other current assets | 42,874 | 38,886 | 3,988 | 10.3% |
| Current assets: | Total current assets | 653,141 | 656,189 | -3,048 | -0.5% |
| Current assets: | Property and equipment | 23,396 | 23,813 | -417 | -1.8% |
| Current assets: | Less - accumulated depreciation and amortization | 18,246 | 17,629 | 617 | 3.5% |
| Current assets: | Property and equipment, net | 5,150 | 6,184 | -1,034 | -16.7% |
| Current assets: | Intangible assets, net | 9,167 | 20,167 | -11,000 | -54.5% |
| Current assets: | Goodwill | 502,067 | 501,756 | 311 | 0.1% |
| Current assets: | Deferred commissions, net | 40,727 | 44,452 | -3,725 | -8.4% |
| Current assets: | Deferred income taxes | 57,873 | 1,982 | 55,891 | 2819.9% |
| Current assets: | Other assets, net | 26,052 | 28,641 | -2,589 | -9.0% |
| Current assets: | % | 1,294,177 | 1,259,371 | 34,806 | 2.8% |
| Current liabilities: | Trade accounts payable | 129,730 | 112,271 | 17,459 | 15.6% |
| Current liabilities: | Accrued payroll and related expenses | 55,063 | 50,776 | 4,287 | 8.4% |
| Current liabilities: | Other accrued expenses | 40,280 | 38,586 | 1,694 | 4.4% |
| Current liabilities: | Deferred revenue | 39,714 | 45,885 | -6,171 | -13.4% |
| Current liabilities: | Total current liabilities | 264,787 | 247,518 | 17,269 | 7.0% |
| Current liabilities: | Other liabilities | 57,411 | 62,994 | -5,583 | -8.9% |
| Stockholders' equity: | Preferred stock | n/a | |||
| Stockholders' equity: | Common stock | 16,183 | 15,918 | 265 | 1.7% |
| Stockholders' equity: | Additional paid-in capital | 2,129,554 | 2,045,316 | 84,238 | 4.1% |
| Stockholders' equity: | Retained earnings | 1,459,310 | 1,313,358 | 145,952 | 11.1% |
| Stockholders' equity: | Accumulated other comprehensive income | 5,640 | 4,295 | 1,345 | 31.3% |
| Stockholders' equity: | Treasury stock, at cost | -2,638,708 | -2,430,028 | -208,680 | 8.6% |
| Stockholders' equity: | Total stockholders' equity | 971,979 | 948,859 | 23,120 | 2.4% |
| Stockholders' equity: | % | 1,294,177 | 1,259,371 | 34,806 | 2.8% |
Cash Flow
For the three months ended March 31, — (Dollars in thousands)
| For the three months ended March 31, – 2026 | For the three months ended March 31, – 2025 | ||
|---|---|---|---|
| Cash flows from operating activities: | Net earnings (loss) | 70,912 | -6,267 |
| Cash flows from operating activities: | Earnings from discontinued operations, net of tax | -1,176 | |
| Non-cash operating activities: | Depreciation and amortization | 3,320 | 3,803 |
| Non-cash operating activities: | Loss on disposal or impairment of assets | 8 | 44 |
| Non-cash operating activities: | Lease-related impairment and restructuring charges | -28 | |
| Non-cash operating activities: | Gain on sale of strategic investments | -112 | -515 |
| Non-cash operating activities: | Loss on marketable equity securities | 124 | 206 |
| Non-cash operating activities: | Provision for doubtful accounts | 696 | -453 |
| Non-cash operating activities: | Deferred income taxes | -56,385 | -496 |
| Non-cash operating activities: | Non-cash stock compensation expense | 18,930 | 24,166 |
| Changes in operating assets and liabilities: | Accounts receivable, net | 4,909 | 25,187 |
| Changes in operating assets and liabilities: | Deferred commissions | -492 | 46 |
| Changes in operating assets and liabilities: | Other assets | 4,314 | 4,703 |
| Changes in operating assets and liabilities: | Accounts payable and other liabilities | 15,915 | 11,738 |
| Changes in operating assets and liabilities: | Income taxes | 4,142 | -523 |
| Changes in operating assets and liabilities: | Deferred revenue | -6,203 | 969 |
| Changes in operating assets and liabilities: | Net cash provided by operating activities | 58,902 | 62,580 |
| Cash flows from investing activities: | Capital expenditures | -289 | -293 |
| Cash flows from investing activities: | Proceeds from sale of strategic investment | 112 | 763 |
| Cash flows from investing activities: | Net cash provided by (used in) investing activities | -177 | 470 |
| Cash flows from financing activities: | Proceeds related to the issuance of common stock under stock and employee benefit plans | 103 | 202 |
| Cash flows from financing activities: | Shares repurchased for tax withholdings upon vesting of stock-based awards | -570 | -1,026 |
| Cash flows from financing activities: | Acquisition of treasury stock | -75,604 | -25,447 |
| Cash flows from financing activities: | Net cash used in financing activities | -76,071 | -26,271 |
| Cash flows from financing activities: | Net cash provided by (used in) continuing operations | -17,346 | 36,779 |
| Cash flows from discontinued operations: | From operating activities | 1,176 | -798 |
| Cash flows from discontinued operations: | Net cash provided by (used in) discontinued operations | 1,176 | -798 |
| Cash flows from discontinued operations: | Net cash provided by (used in) continuing and discontinued operations | -16,170 | 35,981 |
Cash Flow
For the three months ended March 31, — (Dollars in thousands)
| For the three months ended March 31, – 2026 | For the three months ended March 31, – 2025 | ||
|---|---|---|---|
| Effect of exchange rate changes on cash | -171 | 580 | |
| Net change in cash, cash equivalents and restricted cash | -16,341 | 36,561 | |
| Cash, cash equivalents and restricted cash at beginning of period | 395,888 | 377,365 | |
| Cash, cash equivalents and restricted cash at end of period | 379,547 | 413,926 | |
| Supplemental cash flow information: | Cash paid for income taxes, net | 1,642 | 558 |
| Supplemental cash flow information: | Cash received for income taxes, net from discontinued operations | -1,863 |
Cash Flow
For the twelve months ended March 31, — (Dollars in thousands)
| For the twelve months ended March 31, – 2026 | For the twelve months ended March 31, – 2025 | ||
|---|---|---|---|
| Cash flows from operating activities: | Net earnings (loss) | 145,952 | -814 |
| Cash flows from operating activities: | Earnings from discontinued operations, net of tax | -1,176 | -1,688 |
| Non-cash operating activities: | Depreciation and amortization | 13,399 | 17,207 |
| Non-cash operating activities: | Loss on disposal or impairment of assets | 148 | 85 |
| Non-cash operating activities: | Lease-related impairment and restructuring charges | 617 | 14 |
| Non-cash operating activities: | Gain on sale of strategic investments | -159 | -515 |
| Non-cash operating activities: | Loss on marketable equity securities | 260 | 206 |
| Non-cash operating activities: | Provision for doubtful accounts | 1,991 | 695 |
| Non-cash operating activities: | Deferred income taxes | -56,272 | -447 |
| Non-cash operating activities: | Non-cash stock compensation expense | 82,988 | 107,979 |
| Changes in operating assets and liabilities: | Accounts receivable, net | -28,345 | 3,547 |
| Changes in operating assets and liabilities: | Deferred commissions | 3,725 | 3,691 |
| Changes in operating assets and liabilities: | Other assets | 2,477 | 2,105 |
| Changes in operating assets and liabilities: | Accounts payable and other liabilities | 3,023 | 3,573 |
| Changes in operating assets and liabilities: | Income taxes | 5,437 | 3,430 |
| Changes in operating assets and liabilities: | Deferred revenue | -6,310 | 14,897 |
| Changes in operating assets and liabilities: | Net cash provided by operating activities | 167,755 | 153,965 |
| Cash flows from investing activities: | Capital expenditures | -1,376 | -1,042 |
| Cash flows from investing activities: | Cash paid in acquisitions, net of cash received | -595 | -1,951 |
| Cash flows from investing activities: | Purchases of investments | -1,967 | |
| Cash flows from investing activities: | Proceeds from sales of investments | 26,989 | |
| Cash flows from investing activities: | Proceeds from sale of strategic investment | 359 | 763 |
| Cash flows from investing activities: | Purchases of strategic investments | -3,320 | -1,400 |
| Cash flows from investing activities: | Net cash provided by (used in) investing activities | -4,932 | 21,392 |
| Cash flows from financing activities: | Proceeds related to the issuance of common stock under stock and employee benefit plans | 8,207 | 8,833 |
| Cash flows from financing activities: | Shares repurchased for tax withholdings upon vesting of stock-based awards | -13,017 | -10,331 |
| Cash flows from financing activities: | Acquisition of treasury stock | -194,534 | -101,198 |
| Cash flows from financing activities: | Net cash used in financing activities | -199,344 | -102,696 |
| Cash flows from financing activities: | Net cash provided by (used in) continuing operations | -36,521 | 72,661 |
| Cash flows from discontinued operations: | From operating activities | 1,176 | 1,688 |
| Cash flows from discontinued operations: | Net cash provided by discontinued operations | 1,176 | 1,688 |
| Cash flows from discontinued operations: | Net cash provided by (used in) continuing and discontinued operations | -35,345 | 74,349 |
Full release
This communication contains forward-looking statements within the meaning of, and subject to the protections of, Section 27A of the Securities
Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, concerning LiveRamp, Publicis, the proposed transaction and other matters. Forward-looking statements contained herein could include, among other things, statements regarding the anticipated timing of the consummation of the proposed transaction; statements about management’s confidence in and strategies for performance of the combined businesses; expectations for new and existing products, technologies and opportunities; and expectations regarding growth, sales, cash flows, and earnings. Forward-looking statements can be identified by the use of such terms as “may,”
“could,” “expect,” “anticipate,” “intend,” “believe,” “likely,”
“estimate,” “outlook,” “plan,” “contemplate,” “project,” “target” or other comparable terms. These forward-looking statements are not guarantees of future performance. Actual results may differ materially from the forward-looking statements as a result of a number of risks and uncertainties, many of which are outside the control of LiveRamp... (trunca Many factors could cause actual future events to differ materially from the forward-looking statements in this communication including, but not limited to: economic uncertainties that could impact LiveRamp or LiveRamp’s suppliers, customers and partners, geopolitical circumstances, including risk related to tariffs and other trade restrictions, the possibility of a recession, general inflationary pressure and high interest rates; the ability and willingness of LiveRamp’s customers to renew their agreements with LiveRamp upon their expiration; LiveRamp’s ability to add new customers and upsell within LiveRamp’s subscription business; LiveRamp’s reliance upon partners, including data suppliers, who may withdraw or withhold data from LiveRamp; increased competition and rapidly changing technology that could impact LiveRamp’s products and services; LiveRamp’s ability to keep up with rapidly changing technology practices in LiveRamp’s products and services or that expected benefits from utilization of technological innovations
(including AI) may not be realized as soon as expected or at all; the risk that LiveRamp fails to realize the potential benefits of or have difficulty integrating acquired businesses; and LiveRamp’s inability to attract, motivate and retain talent. Additional risks include maintaining LiveRamp’s culture and LiveRamp’s ability to innovate and evolve while operating in a hybrid work environment, with some employees working remotely at least some of the time within a rapidly changing industry, while also avoiding disruption from reductions in LiveRamp’s current workforce as well as disruptions resulting from acquisition, divestiture and other activities affecting LiveRamp’s workforce. LiveRamp’s global workforce strategy could possibly encounter difficulty and not be as beneficial as planned. LiveRamp’s international operations are also subject to risks, including the performance of third parties as well as impacts from war and civil unrest, that may harm LiveRamp’s business. The risk of a significant breach of the confidentiality of the information or the security of LiveRamp’s or LiveRamp’s customers’, suppliers’, or other partners’ data and/or computer systems, or the risk that LiveRamp’s current insurance coverage may not be adequate for such a breach, that an insurer might deny coverage for a claim or that such insurance will continue to be available to LiveRamp on commercially reasonable terms, or at all, could be detrimental to LiveRamp’s business, reputation and results of operations. Other business risks include unfavorable publicity and negative public perception about LiveRamp’s industry; interruptions or delays in service from data center or cloud hosting vendors LiveRamp relies upon; and LiveRamp’s dependence on the continued availability of third-party data hosting and transmission services. LiveRamp’s clients’ ability to use data on LiveRamp’s platform could be restricted if the industry’s use of third-party cookies and tracking technology declines due to technology platform changes, regulation or increased user controls. Continued changes in the judicial, legislative, regulatory, accounting, cultural and consumer environments affecting LiveRamp’s business, including but not limited to litigation, investigations, legislation, regulations and customs at the state, federal and international levels relating to information collection and use represents a risk, as well as changes in tax laws and regulations that are applied to LiveRamp’s customers which could cause enterprise software budget tightening. In addition, third parties may claim that LiveRamp is infringing their intellectual property or may infringe LiveRamp’s intellectual property which could result in competitive injury and / or the incurrence of significant costs and draining of LiveRamp’s resources. Factors that could cause actual future events to differ materially from the forward looking-statements in this communication in regard to the proposed transaction concerning LiveRamp and Publicis include, but are not limited to: (1) failure of the closing conditions in the merger agreement to be satisfied, or any unexpected delay in closing the proposed transaction or the occurrence of any event, change, or other circumstance that could give rise to the right of one or multiple of the parties to terminate the definitive agreement between Publicis and LiveRamp; (2) the possibility that the transaction does not close when expected or at all because required regulatory, shareholder, or other approvals are not received or satisfied on a timely basis or at all; (3) the possibility that the transaction may be more expensive to complete than anticipated, including as a result of unexpected factors or events, including those resulting from the announcement, pendency or completion of the transaction; (4) risks that the new businesses will not be integrated successfully or that the combined companies will not realize estimated cost savings, value of certain tax assets, synergies and growth or that such benefits may take longer to realize than expected; (5) failure to realize anticipated benefits of the combined operations; (6) risks relating to unanticipated costs of integration; (7) ability to hire and retain key personnel; (8) ability to successfully integrate the companies’ businesses; (9) the potential impact of announcement or consummation of the proposed transactions on relationships with third parties, including clients, employees and competitors, including reputational risk; (10) ability to attract new clients and retain existing clients in the manner anticipated; (11) reliance on and integration of information technology systems; (12) suffering reduced profits or losses as a result of intense competition; or (13) potential litigation that may be instituted against LiveRamp or its directors or... (truncated)stive. You should carefully consider the foregoing factors and the other risks and uncertainties that affect the parties’ businesses, including those described in LiveRamp’s Annual Report on Form 10-K for the year ended March 31, 2025, in Part I “Cautionary Statements
Relevant to Forward-Looking Information” and Part I, Item 1A, “Risk Factors,” as updated by subsequent Quarterly
Reports on Form 10-Q, which are filed with the Securities and Exchange Commission (the “SEC”) and those described in documents Publicis has filed with the Autorité des Marchés Financiers (the French securities regulator). The parties do not undertake, nor do they have, any obligation to provide updates or to revise any forward-looking statements.
P⁶
NO
OFFER OR SOLICITATION
This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, and applicable regulations.
ADDITIONAL
INFORMATION AND WHERE TO FIND IT
In connection with the proposed transaction, LiveRamp Holdings, Inc. will be filing documents with the SEC, including preliminary and definitive proxy statements relating to the proposed transaction (the “proxy statement”). The definitive proxy statement will be mailed to LiveRamp’s shareholders in connection with the proposed transaction. BEFORE MAKING ANY VOTING DECISION, INVESTORS
AND SECURITY HOLDERS ARE URGED TO READ THE PRELIMINARY AND DEFINITIVE PROXY STATEMENTS AND ANY OTHER DOCUMENTS TO BE FILED WITH THE SEC
IN CONNECTION WITH THE PROPOSED TRANSACTION OR INCORPORATED BY REFERENCE IN THE PROXY STATEMENT WHEN THEY BECOME AVAILABLE BECAUSE THEY
WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION. Any vote in respect of resolutions to be proposed at LiveRamp’s shareholder meeting to approve the proposed transaction should be made only on the basis of the information contained in LiveRamp’s proxy statement and documents incorporated by reference therein. Investors and security holders may obtain free copies of these documents
(when they are available) and other related documents filed with the SEC at the SEC’s website at www.sec.gov or on LiveRamp’s website at www.liveramp.com.
PARTICIPANTS
IN THE SOLICITATION
Publicis,
LiveRamp and their respective directors and certain of their respective executive officers may be deemed to be participants in the solicitation of proxies from the shareholders of LiveRamp in respect of the proposed transactions contemplated by the proxy statement. Information regarding the persons who are, under the rules of the SEC, participants in the solicitation of the shareholders of LiveRamp in connection with the proposed transaction, including a description of their direct or indirect interests, by security holdings or otherwise, will be set forth in the proxy statement when it is filed with the SEC. Information about the directors and executive officers of LiveRamp and their ownership of shares of LiveRamp common stock and other securities of LiveRamp can be found in the sections entitled “Nominees and Continuing Directors,” “Stock Ownership,” “Compensation Discussion and Analysis,” “Compensation
Tables,” and “Non-Employee Director Compensation” included in LiveRamp’s proxy statement in connection with its
2025 Annual Meeting of Shareholders, filed with the SEC on June 27, 2025; in the Form 3 and Form 4 initial statements of beneficial ownership and statements of changes in beneficial ownership filed with the SEC by LiveRamp’s directors and executive officers; and in other documents subsequently filed by LiveRamp with the SEC, including LiveRamp’s proxy statement relating to the proposed transaction when it becomes available. Investors and security holders may obtain free copies of these documents and other related documents filed with the SEC at the SEC’s website at www.sec.gov or on LiveRamp’s website at www.liveramp.com.
P⁷
The financial information set forth in this press release reflects estimates based on information available at this time.
LiveRamp assumes no obligation and does not currently intend to update these forward-looking statements.
To automatically receive LiveRamp financial news by email, please visit www.LiveRamp.com and subscribe to email alerts.
For more information, contact:
LiveRamp
Investor Relations
Investor.Relations@LiveRamp.com
LiveRamp
Ⓡ and RampID
TM and all other LiveRamp marks contained herein are trademarks or service marks of LiveRamp, Inc. All other marks are the property of their respective owners.
P⁸
LIVERAMP
HOLDINGS, INC. AND SUBSIDIARIES